Avita Medical, Inc.

Good day and thank you for standing by. Welcome to Aveda Medical's second quarter 2023 earnings call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your host today, Jessica Ekberg, Director of Investor Relations. Please go ahead.

Thank you, Operator.

Welcome to Avita Medical's second quarter 2023 earnings call. Before we begin, let me remind you that this call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results to differ materially from any expectations expressed or implied by the forward-looking statement. Please review VITA Medical's most recent filings with the SEC, specifically the risk factors described within the Form 10-Q for the quarter ended June 30, 2023 for additional information. Any forward-looking statements provided during this call are based on management's expectations as of today. Aveda Medical's press release with second quarter 2023 results is available on our website, www.avedamedical.com, under the Investors section. A recording of today's call will be available on our website by 5 p.m. Pacific time today. Joining me on today's call are Jim Corbett, Chief Executive Officer, and David O'Toole, Chief Financial Officer. I will now turn the call over to Jim for his comments.